Ligand validation:4HDP

G52: (3R,3aS,3bR,6aS,7aS)-octahydrodifuro[2,3-b:3',2'-d]furan-3-yl [(1S,2R)-1-benzyl-2-hydroxy-3-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}propyl]carbamate

G52 is a Ligand Of Interest in 4HDP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HDP_G52_B_401	87%	38%	0.09	0.962	1.06	1.36	3	9	0	0	100%	0.7
4HE9_G52_A_401	89%	40%	0.091	0.97	1.05	1.28	2	7	20	0	100%	0.53
4HDF_G52_A_401	86%	37%	0.096	0.965	1.24	1.25	4	8	2	0	100%	0.6
3OK9_G52_A_401	84%	32%	0.092	0.952	1.34	1.37	2	13	6	0	100%	0.55
4HEG_G52_A_401	80%	33%	0.109	0.959	1.22	1.41	2	10	2	0	100%	0.55
4HDB_G52_A_401	77%	31%	0.116	0.955	1.3	1.43	2	8	8	0	100%	0.55
8DCH_G52_A_201	96%	42%	0.071	0.982	1.02	1.24	3	5	1	0	100%	0.5
4J54_G52_A_201	95%	33%	0.065	0.969	1.19	1.44	3	8	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.